ASCO 2019 | Lymphoma: predicting response

Frederick Locke

Frederick Locke, MD, of the Moffitt Cancer Center, Tampa, FL, discusses the methods that can be used to predict durable response in lymphoma patients being treated with CAR T-cell therapy. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video